mycophenolic-acid and Papilledema

mycophenolic-acid has been researched along with Papilledema* in 2 studies

Other Studies

2 other study(ies) available for mycophenolic-acid and Papilledema

Article	Year
Neuro-Behçet's disease presenting with tumour-like lesions and responding to rituximab. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2016, Volume: 32 We describe a patient with neuro-Behçets disease (NBD) that presented with symptoms of raised intracranial pressure including papilloedema. MRI revealed tumour-like lesions which, on biopsy, confirmed an active vasculitis. Treatment was commenced with prednisone and cyclophosphamide which proved unsuccessful with enlargement of the cerebral mass lesions. Infliximab and mycophenolate were trialled also without benefit. The patient required ventriculoperitoneal shunts to relieve the symptoms of hydrocephalus. Rituximab was then commenced with significant symptomatic and imaging improvement. The case is unique, in our experience, in the need for shunting to relieve the symptoms of hydrocephalus related to vasculitis. Topics: Adult; Behcet Syndrome; Brain; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Imaging; Mycophenolic Acid; Papilledema; Prednisone; Rituximab; Treatment Outcome	2016
Pseudopapilledema in a pediatric kidney transplant recipient. Pediatric transplantation, 2010, Volume: 14, Issue:7 IIH is a syndrome of increased intracranial pressure characterized by headache, visual disturbance, papilledema with normal cranial neuroimaging. It is associated with many factors in childhood. From the renal perspective renal insufficiency, chronic dialysis, steroid treatment, and recombinant human growth hormone have been associated with IIH. It has also been described in pediatric recipients several months to years following kidney transplantation. In this study, we present a pediatric kidney transplant recipient receiving CyA, prednisone, and mycophenolate mofetil who was discovered to have pseudopapilledema during routine ophthalmological examination. He had no additional signs of increased intracranial pressure. Awareness of possible side effects in the follow-up of these patients may improve management of these children. Topics: Adolescent; Angiography; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Papilledema; Prednisone; Pseudotumor Cerebri; Recombinant Fusion Proteins; Syndrome	2010

Article

Year

Neuro-Behçet's disease presenting with tumour-like lesions and responding to rituximab.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2016, Volume: 32

We describe a patient with neuro-Behçets disease (NBD) that presented with symptoms of raised intracranial pressure including papilloedema. MRI revealed tumour-like lesions which, on biopsy, confirmed an active vasculitis. Treatment was commenced with prednisone and cyclophosphamide which proved unsuccessful with enlargement of the cerebral mass lesions. Infliximab and mycophenolate were trialled also without benefit. The patient required ventriculoperitoneal shunts to relieve the symptoms of hydrocephalus. Rituximab was then commenced with significant symptomatic and imaging improvement. The case is unique, in our experience, in the need for shunting to relieve the symptoms of hydrocephalus related to vasculitis.

Topics: Adult; Behcet Syndrome; Brain; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Imaging; Mycophenolic Acid; Papilledema; Prednisone; Rituximab; Treatment Outcome

2016

Pseudopapilledema in a pediatric kidney transplant recipient.

Pediatric transplantation, 2010, Volume: 14, Issue:7

IIH is a syndrome of increased intracranial pressure characterized by headache, visual disturbance, papilledema with normal cranial neuroimaging. It is associated with many factors in childhood. From the renal perspective renal insufficiency, chronic dialysis, steroid treatment, and recombinant human growth hormone have been associated with IIH. It has also been described in pediatric recipients several months to years following kidney transplantation. In this study, we present a pediatric kidney transplant recipient receiving CyA, prednisone, and mycophenolate mofetil who was discovered to have pseudopapilledema during routine ophthalmological examination. He had no additional signs of increased intracranial pressure. Awareness of possible side effects in the follow-up of these patients may improve management of these children.

Topics: Adolescent; Angiography; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Papilledema; Prednisone; Pseudotumor Cerebri; Recombinant Fusion Proteins; Syndrome

2010